Nothing Special   »   [go: up one dir, main page]

AU5850798A - Polynucleotides encoding proexendin, and methods and uses thereof - Google Patents

Polynucleotides encoding proexendin, and methods and uses thereof

Info

Publication number
AU5850798A
AU5850798A AU58507/98A AU5850798A AU5850798A AU 5850798 A AU5850798 A AU 5850798A AU 58507/98 A AU58507/98 A AU 58507/98A AU 5850798 A AU5850798 A AU 5850798A AU 5850798 A AU5850798 A AU 5850798A
Authority
AU
Australia
Prior art keywords
proexendin
methods
polynucleotides encoding
polynucleotides
encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58507/98A
Inventor
Daniel J. Drucker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
1149336 Ontario Inc
Original Assignee
1149336 Ontario Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9702582.9A external-priority patent/GB9702582D0/en
Application filed by 1149336 Ontario Inc filed Critical 1149336 Ontario Inc
Publication of AU5850798A publication Critical patent/AU5850798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU58507/98A 1997-02-05 1998-02-04 Polynucleotides encoding proexendin, and methods and uses thereof Abandoned AU5850798A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3741297P 1997-02-05 1997-02-05
US60037412 1997-02-05
GB9702582 1997-02-07
GBGB9702582.9A GB9702582D0 (en) 1997-02-07 1997-02-07 Polynucleotides
PCT/CA1998/000071 WO1998035033A1 (en) 1997-02-05 1998-02-04 Polynucleotides encoding proexendin, and methods and uses thereof

Publications (1)

Publication Number Publication Date
AU5850798A true AU5850798A (en) 1998-08-26

Family

ID=26310953

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58507/98A Abandoned AU5850798A (en) 1997-02-05 1998-02-04 Polynucleotides encoding proexendin, and methods and uses thereof

Country Status (5)

Country Link
EP (1) EP0981611A1 (en)
JP (1) JP2001512307A (en)
AU (1) AU5850798A (en)
CA (1) CA2279836A1 (en)
WO (1) WO1998035033A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2499211A1 (en) * 1999-05-17 2000-11-23 Conjuchem Inc. Modified peptides yy and conjugates thereof
EP1076066A1 (en) 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
US6528486B1 (en) 1999-07-12 2003-03-04 Zealand Pharma A/S Peptide agonists of GLP-1 activity
RU2376314C2 (en) 2002-10-02 2009-12-20 Зилэнд Фарма А/С Stabilised compounds of exendin-4
EP2038423B1 (en) 2006-06-21 2012-12-26 Biocon Limited A method of producing biologically active polypeptide having insulinotropic activity
JP2010502670A (en) 2006-09-07 2010-01-28 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Combination therapy for diabetes mellitus
CA2963857A1 (en) 2007-06-04 2008-12-11 Ben-Gurion University Of The Negev Research And Development Authority Tri-aryl compounds and compositions comprising the same
CA3016451A1 (en) 2008-10-17 2010-04-22 Sanofi-Aventis Deutschland Gmbh Combination of an insulin and a glp-1 agonist
HUE037735T2 (en) 2009-11-13 2018-09-28 Sanofi Aventis Deutschland PHARMACEUTICAL COMPOSITION COMPRISING desPro36Exendin-4(1-39)-Lys6-NH2 AND METHIONINE
US10029011B2 (en) 2009-11-13 2018-07-24 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine
CA2797133C (en) 2010-04-27 2019-08-06 Zealand Pharma A/S Peptide conjugates of glp-1 receptor agonists and gastrin and their use
KR101823320B1 (en) 2010-08-30 2018-01-31 사노피-아벤티스 도이칠란트 게엠베하 Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
BR112014004726A2 (en) 2011-08-29 2017-04-04 Sanofi Aventis Deutschland pharmaceutical combination for use in glycemic control in type 2 diabetes patients
AR087744A1 (en) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE
MX2014005351A (en) 2011-11-03 2014-05-28 Zealand Pharma As Glp-1 receptor agonist peptide gastrin conjugates.
BR112015001451B1 (en) 2012-07-23 2022-03-29 Zealand Pharma A/S Compound, nucleic acid construct, expression vector, host cell, pharmaceutical composition, use of a compound or its pharmaceutically acceptable salt or solvate
TWI608013B (en) 2012-09-17 2017-12-11 西蘭製藥公司 Glucagon analogues
TWI780236B (en) 2013-02-04 2022-10-11 法商賽諾菲公司 Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
US9988429B2 (en) 2013-10-17 2018-06-05 Zealand Pharma A/S Glucagon analogues
UA122767C2 (en) 2013-10-17 2021-01-06 Зіленд Фарма А/С Acylated glucagon analogues
CN106061940A (en) 2013-11-05 2016-10-26 本古里安大学内盖夫研究发展局 Compounds for the treatment of diabetes and disease complications arising from same
MX2016005556A (en) 2013-11-06 2016-07-15 Zealand Pharma As Gip-glp-1 dual agonist compounds and methods.
CA2929107C (en) 2013-11-06 2023-09-26 Zealand Pharma A/S Glucagon-glp-1-gip triple agonist compounds
RU2016132342A (en) 2014-01-09 2018-02-14 Санофи STABILIZED PHARMACEUTICAL COMPOSITIONS BASED ON INSULIN ANALOGUES AND / OR INSULIN DERIVATIVES
CA2932875A1 (en) 2014-01-09 2015-07-16 Sanofi Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives
EP3091964A1 (en) 2014-01-09 2016-11-16 Sanofi Stabilized pharmaceutical formulations of insulin aspart
AU2015340586B2 (en) 2014-10-29 2020-04-30 Zealand Pharma A/S GIP agonist compounds and methods
CR20170314A (en) 2014-12-12 2017-10-20 Sanofi Aventis Deutschland FORMULATION OF GLARGINE / LIXISENATIDA INSULIN FIXED RELATIONSHIP
TWI748945B (en) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 Treatment type 2 diabetes mellitus patients
TW201705975A (en) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 Treatment of type 2 diabetes mellitus patients
CA2980978A1 (en) 2015-04-16 2016-10-20 Zealand Pharma A/S Acylated glucagon analogue
RU2753193C2 (en) 2016-12-09 2021-08-12 Зилэнд Фарма А/С Acylated double agonists of glp-1/glp-2

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424286A (en) * 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same

Also Published As

Publication number Publication date
WO1998035033A1 (en) 1998-08-13
JP2001512307A (en) 2001-08-21
EP0981611A1 (en) 2000-03-01
CA2279836A1 (en) 1998-08-13

Similar Documents

Publication Publication Date Title
AU5850798A (en) Polynucleotides encoding proexendin, and methods and uses thereof
AU2440997A (en) Calixpyrroles, calixpyridinopyrroles and calixpyridines
AU2487300A (en) Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
ZA982187B (en) Adsorbent construction; and, method.
AU7299796A (en) Cellulases, the genes encoding them and uses thereof
AU1220001A (en) Novel proteins and polynucleotides encoding them
AU6733198A (en) Authentication method
AU7598398A (en) Locking pliers
AU4565197A (en) Colostrinin, and uses thereof
AU3426697A (en) High aspect ratio, microstructure-covered, macroscopic surfaces
ZA983148B (en) Modified TNFÓ, DNA encoding such modified TNFÓ and vacines comprising said TNFÓ and DNA.
AU2681895A (en) 8-aryl-1,6-naphthyridin-5-ones
AU5784000A (en) Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
AU9184998A (en) Processes for producing n,n-dialkylallylamine polymers and n,n-dialkylallylaminepolymers
DE59804842D1 (en) Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
AU7104398A (en) Conopeptides auia, auib and auic
AU4001000A (en) Dwf4 polynucleotides, polypeptides and uses thereof
AU6553898A (en) Human secreted protein, ba3.1, and polynucleotides encoding same
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
AU5491599A (en) Irak3 polypeptides, polynucleotides and methods
AU4273099A (en) Polypeptides, polynucleotides and uses thereof
AU8919098A (en) Fumonosin resistance
AU7130998A (en) Ethyleneimine-containing resins, manufacture, and use for chemical separations
AU1571299A (en) Polypeptides, polynucleotides and uses thereof